Study on the clinical effect of combined treatment of gold Bifidobacterium and Smecta in children with diarrhea
小儿腹泻患儿应用金双歧与思密达联合治疗的临床应用效果研究

摘要

目的 研究金双歧与思密达联合治疗用于小儿腹泻患儿中的效果。方法 本次的研究时间在2021.1月至2022.1月，研究对象是这期间我院收治的100例小儿腹泻患者，根据治疗方法的不同分成两组，接受单一思密达治疗的为对照组，接受思密达联合金双歧治疗的为实验组，对患者分别治疗后的临床效果展开比较。结果 实验组最终的临床效果优于对照组，P＜0.05。实验组治疗过程中以及治疗后出现的不良反应情况均显著低于对照组（实验组发生率为2%，对照组发生率为20%），P＜0.05。实验组治疗后患儿症状（即腹泻、发热、呕吐等症状）改善的时间显著短于对照组，P＜0.05。结论 将金双歧与思密达药物联合用于小儿腹泻中，可减少患儿用药后的不良反应，加快患儿疾病恢复的时间。

Abstract

Objective: To study the effect of combined treatment of jinbifi and Smecta on children with diarrhea.
Methods: This study was conducted from January 2021 to January 2022. The subjects were 100 children with diarrhea admitted to our hospital during this period. According to different treatment methods, they were divided into two groups. The control group was treated with Smecta alone and the experimental group was treated with Smecta combined with gold Bifidobacterium. The clinical effects of the patients after treatment were compared.
Results: the final clinical effect of the experimental group was better than that of the control group (P < 0.05). The adverse reactions of the experimental group during and after treatment were significantly lower than those of the control group (the incidence of the experimental group was 2%, and the incidence of the control group was 20%) (P < 0.05). After treatment, the improvement time of children's symptoms (i.e. diarrhea, fever, vomiting, etc.) in the experimental group was significantly shorter than that in the control group (P < 0.05).
Conclusion  : the combination of Golden Bifidobacterium and Smecta in children with diarrhea can reduce the adverse reactions of children and accelerate the recovery time of children.